Literature DB >> 466962

The acute radiation syndrome. A memorial to William Michael Court-Brown.

C E Danjoux, W D Rider, P J Fitzpatrick.   

Abstract

The pattern of symptoms in 189 patients irradiated with a large single dose to one half of the body are described. Radiation sickness developed in 83 and 39% of upper half-body irradiation and lower half-body irradiation treatments respectively and the incidence is not reduced by sedatives or anti-emetics. Following treatment there is a latent period up to 90 min before a phase of acute upset and nausea and vomiting starts. This phase persists for about 6h with an average of six bouts of vomiting and is then followed by recovery.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 466962     DOI: 10.1016/s0009-9260(79)80203-2

Source DB:  PubMed          Journal:  Clin Radiol        ISSN: 0009-9260            Impact factor:   2.350


  8 in total

1.  A double-blind, placebo-controlled trial of i.v. dolasetron mesilate in the prevention of radiotherapy-induced nausea and vomiting in cancer patients.

Authors:  P Bey; P M Wilkinson; M Resbeut; S Bourdin; O Le Floch; W Hahne; N Claverie
Journal:  Support Care Cancer       Date:  1996-09       Impact factor: 3.603

2.  Tropisetron, a new 5-HT3-receptor antagonist, in the prevention of radiation-induced nausea, vomiting and diarrhoea.

Authors:  B Sorbe; A M Berglind
Journal:  Drugs       Date:  1992       Impact factor: 9.546

3.  Proinflammatory effects of local abdominal irradiation on rat gastrointestinal tract.

Authors:  M G Buell; R K Harding
Journal:  Dig Dis Sci       Date:  1989-03       Impact factor: 3.199

Review 4.  Factors influencing the choice of 5-HT3-receptor antagonist antiemetics: focus on elderly cancer patients.

Authors:  Cesare Gridelli; Matti Aapro
Journal:  Support Care Cancer       Date:  2004-03-04       Impact factor: 3.603

Review 5.  Dolasetron. A review of its pharmacology and therapeutic potential in the management of nausea and vomiting induced by chemotherapy, radiotherapy or surgery.

Authors:  J A Balfour; K L Goa
Journal:  Drugs       Date:  1997-08       Impact factor: 11.431

Review 6.  A History of Drug Discovery for Treatment of Nausea and Vomiting and the Implications for Future Research.

Authors:  Gareth J Sanger; Paul L R Andrews
Journal:  Front Pharmacol       Date:  2018-09-04       Impact factor: 5.810

7.  Radiation-induced nausea and vomiting: Is ABO blood group as important as radiation and patient-related factors? An observational study.

Authors:  Mohsen Habibi; Amir Namimoghadam; Roghaye Korouni; Paria Fashiri; Sajad Borzoueisileh; Farideh Elahimanesh; Fatemeh Amiri; Ghobad Moradi
Journal:  Medicine (Baltimore)       Date:  2016-08       Impact factor: 1.889

8.  Furazolidone Increases Survival of Mice Exposed to Lethal Total Body Irradiation through the Antiapoptosis and Antiautophagy Mechanism.

Authors:  Shumei Ma; Zhao Jin; Yi Liu; Lin Liu; Hao Feng; Ping Li; Zhujun Tian; Minghua Ren; Xiaodong Liu
Journal:  Oxid Med Cell Longev       Date:  2021-02-04       Impact factor: 6.543

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.